Fourth, the overexpression of TP53-induced glycolysis and apoptosis regulator (TIGAR) is associated with the progression and therapy resistance of ESCC owing to reduced intracellular lactate levels and metabolic reprogramming from glycolysis to glutamine metabolism [46]. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.